Pfizer has been under pressure to show it can capitalize on its COVID-19 windfall, after vaccine revenue almost doubled its sales in a single year.

While Ozempic is sold across Europe, Wegovy is yet to launch in most of the region and has also faced shortages in the U.S.  

What lessons did the healthcare supply chain learn from the COVID-19 pandemic? 

A little-known federal agency in charge of stockpiling vaccines and mobilizing supplies in health emergencies is being reorganized to apply lessons learned in the Covid pandemic.

Biogen Inc.’s new chief executive officer outlined some of his first steps toward his vision for the biotechnology company with plans to boost investment in new drugs the company is developing for Alzheimer’s disease, lupus and other illnesses.

Through its savvy but legal exploitation of the U.S. patent system, Humira’s manufacturer, AbbVie, was able to block competitors from entering the market.

Jamie Wallisch wants companies to recognize that they truly have leverage. “Manufacturers do have an important part to play, even though it seems so high up and far removed,” she says.

BioNTech acquired the Marburg facility in 2020 from Novartis AG, which had used it to produce complex biological medicines.